Legend Biotech (LEGN) Other financing activities (2020 - 2024)

Legend Biotech's Other financing activities history runs 5 years deep, the most recent figure standing at -$150000.0 for Q3 2024.

• Quarterly Other financing activities changed N/A year-over-year to -$150000.0 in Q3 2024, while the trailing twelve-month figure through Sep 2024 was -$221000.0 (down 1373.33% YoY) and the FY2022 annual result came in at -$15000.0, up 98.58% from the prior year.
• Other financing activities was -$150000.0 for Q3 2024 at Legend Biotech, down from -$71000.0 in the prior quarter.
• Across five years, Other financing activities topped out at $2000.0 in Q2 2023 and bottomed at -$1.1 million in Q4 2021.
• A 5-year average of -$203428.6 and a median of -$71000.0 in 2024 frame the typical range for Other financing activities.
• Annual changes were most pronounced in 2022 — Other financing activities surged 98.58% — and 2024, when it tumbled 3650.0%.
• Legend Biotech's Other financing activities stood at -$128000.0 in 2020, then sank by 728.12% to -$1.1 million in 2021, then jumped by 98.58% to -$15000.0 in 2022, then soared by 113.33% to $2000.0 in 2023, then plunged by 7600.0% to -$150000.0 in 2024.
• Business Quant data shows LEGN's Other financing activities at -$150000.0 in Q3 2024, -$71000.0 in Q2 2024, and $2000.0 in Q2 2023.